ANVS homework Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.
set stop lose 12.50
entry $13
exit $16
Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
−4.76EUR
−50.92 MEUR
8.32 M
About Annovis Bio, Inc.
Sector
CEO
Maria-Luisa Maccecchini
Headquarters
Malvern
Website
Employees (FY)
6
Founded
2008
FIGI
BBG00VYKPVY6
Annovis Bio, Inc. is a clinical stage drug platform company, which engages in the development of drugs which aim to treat neurodegenerative diseases such as Alzheimer's (AD) and Parkinson's (PD). Its lead product candidate, Buntanetap, is designed to address AD, PD, and potentially other chronic neurodegenerative diseases. Its product pipeline also includes ANVS405 and ANVS301, which focus on the treatment of traumatic brain injury, stroke, and advanced AD. The company was founded by Maria Luisa Maccecchini in May 2008 and is headquartered in Malvern, PA.
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.
Frequently Asked Questions
The current price of 07X is 6.06 EUR — it has increased by 9.39% in the past 24 hours. Watch ANNOVIS BIO INC stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on GETTEX exchange ANNOVIS BIO INC stocks are traded under the ticker 07X.
07X stock has fallen by 8.60% compared to the previous week, the month change is a 8.32% fall, over the last year ANNOVIS BIO INC has showed a 50.08% decrease.
We've gathered analysts' opinions on ANNOVIS BIO INC future price: according to them, 07X price has a max estimate of 66.86 EUR and a min estimate of 12.07 EUR. Watch 07X chart and read a more detailed ANNOVIS BIO INC stock forecast: see what analysts think of ANNOVIS BIO INC and suggest that you do with its stocks.
07X stock is 21.48% volatile and has beta coefficient of 2.49. Track ANNOVIS BIO INC stock price on the chart and check out the list of the most volatile stocks — is ANNOVIS BIO INC there?
Today ANNOVIS BIO INC has the market capitalization of 67.54 M, it has decreased by 15.18% over the last week.
Yes, you can track ANNOVIS BIO INC financials in yearly and quarterly reports right on TradingView.
ANNOVIS BIO INC is going to release the next earnings report on Aug 5, 2024. Keep track of upcoming events with our Earnings Calendar.
07X earnings for the last quarter are −0.67 EUR per share, whereas the estimation was −0.76 EUR resulting in a 11.82% surprise. The estimated earnings for the next quarter are −0.52 EUR per share. See more details about ANNOVIS BIO INC earnings.
ANNOVIS BIO INC revenue for the last quarter amounts to 0 EUR despite the estimated figure of 0 EUR. In the next quarter revenue is expected to reach 0 EUR.
07X net income for the last quarter is −988.83 K EUR, while the quarter before that showed −20.13 M EUR of net income which accounts for 95.09% change. Track more ANNOVIS BIO INC financial stats to get the full picture.
No, 07X doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Jun 2, 2024, the company has 6.00 employees. See our rating of the largest employees — is ANNOVIS BIO INC on this list?
Like other stocks, 07X shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade ANNOVIS BIO INC stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So ANNOVIS BIO INC technincal analysis shows the sell today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating ANNOVIS BIO INC stock shows the sell signal. See more of ANNOVIS BIO INC technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.